소아용 관류 제품 시장 규모, 점유율, 동향 및 성장 분석 보고서(2026-2034년)

The Pediatric Perfusion Products Market size is expected to reach USD 440.93 Million in 2034 from USD 225.04 Million (2025) growing at a CAGR of 7.76% during 2026-2034.

The Global Pediatric Perfusion Products Market is growing steadily due to rising cases of congenital heart defects and increasing pediatric cardiac surgeries worldwide. Perfusion products, including oxygenators, pumps, and tubing systems, are essential for maintaining circulation during complex heart procedures. Improvements in neonatal and pediatric healthcare infrastructure, particularly in developing economies, are significantly contributing to the expansion of this specialized medical segment.

Growth drivers include technological advancements in miniaturized perfusion systems designed specifically for infants and children. Increasing awareness about early diagnosis and improved surgical success rates are encouraging healthcare providers to adopt advanced perfusion solutions. Government initiatives focused on pediatric healthcare and expanding insurance coverage are further strengthening market growth. Moreover, rising investments in specialized cardiac care centers are enhancing procedural capabilities globally.

Future growth prospects appear promising as innovations continue to improve safety and efficiency in pediatric cardiac surgeries. Development of biocompatible materials and improved monitoring technologies will support better patient outcomes. Expanding healthcare access in emerging markets is expected to increase surgical volumes. As healthcare systems prioritize child health and advanced surgical care, the pediatric perfusion products market is poised for sustained expansion.

Our reports are meticulously crafted to provide clients with comprehensive and actionable insights into various industries and markets. Each report encompasses several critical components to ensure a thorough understanding of the market landscape:

Market Overview: A detailed introduction to the market, including definitions, classifications, and an overview of the industry's current state.

Market Dynamics: In-depth analysis of key drivers, restraints, opportunities, and challenges influencing market growth. This section examines factors such as technological advancements, regulatory changes, and emerging trends.

Segmentation Analysis: Breakdown of the market into distinct segments based on criteria like product type, application, end-user, and geography. This analysis highlights the performance and potential of each segment.

Competitive Landscape: Comprehensive assessment of major market players, including their market share, product portfolio, strategic initiatives, and financial performance. This section provides insights into the competitive dynamics and key strategies adopted by leading companies.

Market Forecast: Projections of market size and growth trends over a specified period, based on historical data and current market conditions. This includes quantitative analyses and graphical representations to illustrate future market trajectories.

Regional Analysis: Evaluation of market performance across different geographical regions, identifying key markets and regional trends. This helps in understanding regional market dynamics and opportunities.

Emerging Trends and Opportunities: Identification of current and emerging market trends, technological innovations, and potential areas for investment. This section offers insights into future market developments and growth prospects.

MARKET SEGMENTATION

By Product

• Pediatric Oxygenators
• Pediatric Arterial Filters
• Pediatric Cannulae
• Hemoconcentrators
• Reservoirs
• Others

By End User

• Hospitals
• Specialty Clinics
• Others

COMPANIES PROFILED

• Medtronic, Terumo Cardiovascular Systems Corporation, LivaNova PLC, BL Lifesciences, Cardinal Health, Getinge AB, Eurosets, Edwards Lifesciences Corporation, Berlin Heart, Sorin Group
• We can customise the report as per your requirements.

TABLE OF CONTENTS

Chapter 1. PREFACE

• 1.1. Market Segmentation & Scope
• 1.2. Market Definition
• 1.3. Information Procurement
  • 1.3.1 Information Analysis
  • 1.3.2 Market Formulation & Data Visualization
  • 1.3.3 Data Validation & Publishing
• 1.4. Research Scope and Assumptions
  • 1.4.1 List of Data Sources

Chapter 2. EXECUTIVE SUMMARY

• 2.1. Market Snapshot
• 2.2. Segmental Outlook
• 2.3. Competitive Outlook

Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK

• 3.1. Market Lineage Outlook
• 3.2. Penetration & Growth Prospect Mapping
• 3.3. Value Chain Analysis
• 3.4. Regulatory Framework
  • 3.4.1 Standards & Compliance
  • 3.4.2 Regulatory Impact Analysis
• 3.5. Market Dynamics
  • 3.5.1 Market Drivers
  • 3.5.2 Market Restraints
  • 3.5.3 Market Opportunities
  • 3.5.4 Market Challenges
• 3.6. Porter's Five Forces Analysis
• 3.7. PESTLE Analysis

Chapter 4. GLOBAL PEDIATRIC PERFUSION PRODUCTS MARKET: BY PRODUCT 2022-2034 (USD MN)

• 4.1. Market Analysis, Insights and Forecast Product
• 4.2. Pediatric Oxygenators Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.3. Pediatric Arterial Filters Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.4. Pediatric Cannulae Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.5. Hemoconcentrators Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.6. Reservoirs Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.7. Others Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 5. GLOBAL PEDIATRIC PERFUSION PRODUCTS MARKET: BY END USER 2022-2034 (USD MN)

• 5.1. Market Analysis, Insights and Forecast End User
• 5.2. Hospitals Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.3. Specialty Clinics Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.4. Others Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 6. GLOBAL PEDIATRIC PERFUSION PRODUCTS MARKET: BY REGION 2022-2034(USD MN)

• 6.1. Regional Outlook
• 6.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 6.2.1 By Product
  • 6.2.2 By End User
  • 6.2.3 United States
  • 6.2.4 Canada
  • 6.2.5 Mexico
• 6.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 6.3.1 By Product
  • 6.3.2 By End User
  • 6.3.3 United Kingdom
  • 6.3.4 France
  • 6.3.5 Germany
  • 6.3.6 Italy
  • 6.3.7 Russia
  • 6.3.8 Rest Of Europe
• 6.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 6.4.1 By Product
  • 6.4.2 By End User
  • 6.4.3 India
  • 6.4.4 Japan
  • 6.4.5 South Korea
  • 6.4.6 Australia
  • 6.4.7 South East Asia
  • 6.4.8 Rest Of Asia Pacific
• 6.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 6.5.1 By Product
  • 6.5.2 By End User
  • 6.5.3 Brazil
  • 6.5.4 Argentina
  • 6.5.5 Peru
  • 6.5.6 Chile
  • 6.5.7 South East Asia
  • 6.5.8 Rest of Latin America
• 6.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 6.6.1 By Product
  • 6.6.2 By End User
  • 6.6.3 Saudi Arabia
  • 6.6.4 UAE
  • 6.6.5 Israel
  • 6.6.6 South Africa
  • 6.6.7 Rest of the Middle East And Africa

Chapter 7. COMPETITIVE LANDSCAPE

• 7.1. Recent Developments
• 7.2. Company Categorization
• 7.3. Supply Chain & Channel Partners (based on availability)
• 7.4. Market Share & Positioning Analysis (based on availability)
• 7.5. Vendor Landscape (based on availability)
• 7.6. Strategy Mapping

Chapter 8. COMPANY PROFILES OF GLOBAL PEDIATRIC PERFUSION PRODUCTS INDUSTRY

• 8.1. Top Companies Market Share Analysis
• 8.2. Company Profiles
  • 8.2.1 Medtronic
  • 8.2.2 Terumo Cardiovascular Systems Corporation
  • 8.2.3 LivaNova PLC
  • 8.2.4 BL Lifesciences
  • 8.2.5 Cardinal Health
  • 8.2.6 Getinge AB
  • 8.2.7 Eurosets
  • 8.2.8 Edwards Lifesciences Corporation
  • 8.2.9 Berlin Heart
  • 8.2.10 Sorin Group